"The closest thing to a COVID 'cure'?
Eli Lilly's combination antibody drug cuts the risk of COVID-19 hospitalization and death by 87%, study finds
- The combination treatment, a mixture of two drugs, recognizes the coronavirus and attaches to it, preventing it from spreading throughout the body
- Half a group of 769 mild-to-moderate COVID-19 patients at high risk of severe illness were given the drugs and another half given the placebo
- There four hospitalizations and zero deaths among the patients given the treatment and 11 hospitalizations and four deaths among the placebo group
- Researchers determined the combination therapy reduced the risk of hospitalization and death by 87 percent compared to a placebo
- Last month, the U.S. agreed to buy 100,000 doses of the antibody therapy, expected to be delivered by the end of the month, for $210 million...Read all.
No comments:
Post a Comment